Several biomarkers for the early diagnosis of AKI have been proposed, including kidney injury molecule-1 (KIM-1), liver-type fatty acid-binding protein (L-FABP), and neutrophil gelatinase-associated lipocalin (NGAL) [7]. This evidence concerns the gene FABP1 and acute kidney injury.